Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06828796 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Early Use of Tacrolimus in HLA-Mismatched Haploidentical Allogeneic Hematopoietic Transplantation With Post-Transplant Cyclophosphamide

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Publications: details revised at 9 of 10 entries
    • Eligibility criteria shortened, about 5 words
  2. Re-verified, no change to tracked fieldsv4
  3. Trial status: Not Yet Recruiting to Recruitingv3 Show 4 more changesShow less
    • Primary completion date: Jun 2027 to Jun 30, 2027
    • Study completion date: Jun 2028 to Jun 30, 2028
    • Start date changed from estimate of Jun 2025 to Jul 3, 2025
    • Site details revised
  4. Primary completion date: May 2027 to Jun 2027v2 Show 4 more changesShow less
    • Study completion date: May 2028 to Jun 2028
    • Start date: May 2025 to Jun 2025
    • Site contact updated
    • Publications: details revised at 10 of 10 entries
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To evalute the safety and efficacy in reducing Cytokine Release Syndrome after hematopoietic stem cell transplantation by introducing immunosuppression earlier in the transplant process
Trial Details
NCT Number NCT06828796
Lead Sponsor Northside Hospital, Inc.
Conditions
(from sponsor)		 Hematologic Disease and Disorders, Hematopoietic Cell Transplant
Related terms Disease, Hematologic Diseases
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov